{"entity":{"type":"insider","cik":"0001678516","url":"/insider/0001678516","json_url":"/insider/0001678516.json","name":"Priebe Waldemar","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":2,"first":"2017-08-18","last":"2023-08-01","span_basis":"filed_date"},"name_variants":[{"name":"Priebe Waldemar","source":"filing","n_filings":2,"first_seen":"2017-08-18","last_seen":"2023-08-01"}],"transactions":[{"id":7914704,"accession":"0000897069-23-001044","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-17","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":1.04,"price_display":"1.04","price_state":"stated","total_value":10400.0,"total_display":"10,400.00","total_whole":"10,400","shares_owned_after":156807.0,"shares_owned_after_display":"156,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-08-01","scope":"insider"},{"id":7914700,"accession":"0000897069-23-001044","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-16","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.09,"price_display":"1.09","price_state":"stated","total_value":5450.0,"total_display":"5,450.00","total_whole":"5,450","shares_owned_after":166807.0,"shares_owned_after_display":"166,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-08-01","scope":"insider"},{"id":7914698,"accession":"0000897069-23-001044","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-15","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":171807.0,"shares_owned_after_display":"171,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-08-01","scope":"insider"},{"id":7914695,"accession":"0000897069-23-001044","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-14","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":10800.0,"total_display":"10,800.00","total_whole":"10,800","shares_owned_after":176807.0,"shares_owned_after_display":"176,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-08-01","scope":"insider"},{"id":7914693,"accession":"0000897069-23-001044","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-13","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":186807.0,"shares_owned_after_display":"186,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-22","filed_date":"2023-08-01","scope":"insider"},{"id":7914690,"accession":"0000897069-23-001044","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-12","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":5500.0,"total_display":"5,500.00","total_whole":"5,500","shares_owned_after":191807.0,"shares_owned_after_display":"191,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-08-01","scope":"insider"},{"id":7914685,"accession":"0000897069-23-001044","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-11","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":196807.0,"shares_owned_after_display":"196,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-08-01","scope":"insider"},{"id":7914681,"accession":"0000897069-23-001044","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-10","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":5650.0,"total_display":"5,650.00","total_whole":"5,650","shares_owned_after":201807.0,"shares_owned_after_display":"201,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-08-01","scope":"insider"},{"id":7914678,"accession":"0000897069-23-001044","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-9","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":6200.0,"total_display":"6,200.00","total_whole":"6,200","shares_owned_after":206807.0,"shares_owned_after_display":"206,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-08-01","scope":"insider"},{"id":7914675,"accession":"0000897069-23-001044","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-8","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.22,"price_display":"1.22","price_state":"stated","total_value":6100.0,"total_display":"6,100.00","total_whole":"6,100","shares_owned_after":211807.0,"shares_owned_after_display":"211,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-08-01","scope":"insider"},{"id":7914671,"accession":"0000897069-23-001044","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-7","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":6750.0,"total_display":"6,750.00","total_whole":"6,750","shares_owned_after":216807.0,"shares_owned_after_display":"216,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-08-01","scope":"insider"},{"id":7914668,"accession":"0000897069-23-001044","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-6","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":6500.0,"total_display":"6,500.00","total_whole":"6,500","shares_owned_after":221807.0,"shares_owned_after_display":"221,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-08-01","scope":"insider"},{"id":7914665,"accession":"0000897069-23-001044","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-5","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":226807.0,"shares_owned_after_display":"226,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-08-01","scope":"insider"},{"id":7914657,"accession":"0000897069-23-001044","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-4","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2798.0,"shares_display":"2,798","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":6799.14,"total_display":"6,799.14","total_whole":"6,799","shares_owned_after":231807.0,"shares_owned_after_display":"231,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2023-08-01","scope":"insider"},{"id":7914654,"accession":"0000897069-23-001044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-3","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":13200.0,"total_display":"13,200.00","total_whole":"13,200","shares_owned_after":234605.0,"shares_owned_after_display":"234,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2023-08-01","scope":"insider"},{"id":7914651,"accession":"0000897069-23-001044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-2","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":2.46,"price_display":"2.46","price_state":"stated","total_value":13530.0,"total_display":"13,530.00","total_whole":"13,530","shares_owned_after":240105.0,"shares_owned_after_display":"240,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2023-08-01","scope":"insider"},{"id":7914646,"accession":"0000897069-23-001044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-23-001044","line_url":"/filing/0000897069-23-001044#line-1","is_derivative":false,"issuer_cik":"0001678516","issuer_name":"CNS Pharmaceuticals, Inc.","issuer_ticker":"CNSP","issuer_name_source":null,"issuer_url":"/issuer/0001678516","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":13585.0,"total_display":"13,585.00","total_whole":"13,585","shares_owned_after":245605.0,"shares_owned_after_display":"245,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2023-08-01","scope":"insider"},{"id":4287341,"accession":"0001144204-17-044232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-044232","line_url":"/filing/0001144204-17-044232#line-1","is_derivative":false,"issuer_cik":"0001659617","issuer_name":"Moleculin Biotech, Inc.","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001659617","owner_cik":"0001678516","owner_name":"Priebe Waldemar","owner_display_name":"Priebe Waldemar","owner_url":"/insider/0001678516","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":1.703,"price_display":"1.70","price_state":"stated","total_value":170300.0,"total_display":"170,300.00","total_whole":"170,300","shares_owned_after":2781573.0,"shares_owned_after_display":"2,781,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001729427","name":"CNS Pharmaceuticals, Inc.","url":"/issuer/0001729427","role":"Ten percent owner","n_filings":1,"first_seen":"2023-08-01","last_seen":"2023-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001659617","name":"Moleculin Biotech, Inc.","url":"/issuer/0001659617","role":"Ten percent owner","n_filings":1,"first_seen":"2017-08-18","last_seen":"2017-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001678516","retrieved_at":"2026-08-26T11:45:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}